Easton Biopharma Gets Registration Certificate for Vitamin K1 Injection
Chengdu Easton Biopharmaceuticals' (SHA:688513) vitamin K1 injection received a drug registration certificate from China's National Medical Products Administration, according to a Shanghai bourse filing on Saturday.The biopharmaceutical company's shares dipped 10% at the close of Monday's trade.The injection is used for the treatment of vitamin K deficiency bleeding and for the prevention of vitamin K deficiency.